OUTCOMES FOR RADIATION THERAPY AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER: WHAT REALLY MATTERS?
dc.contributor.author | Montie, James E. | en_US |
dc.contributor.author | Hussain, Maha H. A. | en_US |
dc.date.accessioned | 2010-06-01T22:26:05Z | |
dc.date.available | 2010-06-01T22:26:05Z | |
dc.date.issued | 2007-09 | en_US |
dc.identifier.citation | Montie, James E.; Hussain, Maha (2007). "OUTCOMES FOR RADIATION THERAPY AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER: WHAT REALLY MATTERS?." BJU International 100(3): 485-486. <http://hdl.handle.net/2027.42/75426> | en_US |
dc.identifier.issn | 1464-4096 | en_US |
dc.identifier.issn | 1464-410X | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/75426 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17608823&dopt=citation | en_US |
dc.format.extent | 97385 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | © 2007 THE AUTHORS; JOURNAL COMPILATION © 2007 BJU INTERNATIONAL | en_US |
dc.title | OUTCOMES FOR RADIATION THERAPY AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER: WHAT REALLY MATTERS? | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.identifier.pmid | 17608823 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/75426/1/j.1464-410X.2007.07057.x.pdf | |
dc.identifier.doi | 10.1111/j.1464-410X.2007.07057.x | en_US |
dc.identifier.source | BJU International | en_US |
dc.identifier.citedreference | Bolla M, Van Poppel H, Collette L et al. Postoperative radiotherapy after radical prostatectomy: a randomized controlled trial (EORTC Trial 22911). Lancet 2005; 366: 572 – 8 | en_US |
dc.identifier.citedreference | Bolla M, Van Poppel H, Collette L, van der Kwast TH on behalf or EORTC Genito-Urinary and Radiation Oncology Groups. ASCO 2007 Prostate Cancer Symposium, Orlando, Florida, February 22–24, 2007 | en_US |
dc.identifier.citedreference | Wirth MP, See WA, McLeod DG et al. Bicalutamide 150 MG in addition to standard care in patients with localized or locally advanced prostate cancer. results from the second analysis of the early prostate cancer program at median follow up of 5.4 years. J Urol 2004; 172: 1865 – 70 | en_US |
dc.identifier.citedreference | 4 FDA Statement. Pfizer stops all torcetrapib clinical trials in interest of patient safety December 3, 2006 Available at http://www.fda.gov/bbs/topics/NEWS/2006/NEW01514.html Accessed May 2007 | en_US |
dc.identifier.citedreference | Williams SD, Stablein DM, Einhorn LH et al. Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathologic stage II testicular cancer. N Eng J Med 1987; 317: 1433 – 8 | en_US |
dc.identifier.citedreference | Stephenson AJ, Shariat SF, Zelefsky MJ et al. salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 2004; 291: 1325 – 32 | en_US |
dc.identifier.citedreference | Buskirk SJ, Pisansly TM, Schild SE et al. Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy. evaluation of prognostic factors and creation of a prognostic scoring system. J Urol 2006; 176: 985 – 90 | en_US |
dc.identifier.citedreference | Thompson I, Tangen CM, Paradelo J et al. Adjuvant radiotherapy for pathologically advanced prostate cancer. JAMA 2006; 296: 2329 – 35 | en_US |
dc.identifier.citedreference | Eggener SE, Roehl KA, Smith ND et al. Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy. J Urol 2005; 173: 1150 – 5 | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.